Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects
NCT ID NCT07680751
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, and quality of life, while also collecting blood samples for future research. The goal is to better understand the long-term course of the disease under current treatments and identify factors that may predict complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal better ways to manage cystinosis and identify biomarkers that predict complications, potentially improving long-term care.
- What could go wrong
- As an observational study, it does not test a new treatment, so it cannot directly lead to a cure or new therapy. Results may take years to influence clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTINOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP_ Hôpital Charles Foix
Ivry-sur-Seine, Île-de-France Region, 94200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Newborn screening study aims to catch rare diseases at birth
- Scientists investigate why cystinosis affects skin color
- Rare disease database aims to boost cystinosis care across europe
- Experimental gene therapy aims to fix cystinosis at the source
- Cystinosis study probes medication adherence and brain risks
- Cystinosis drug under Long-Term watch: could cysteamine be key?